Lumida
/SVRA
⌘K
Savara Inc

Savara Inc

SVRA
$5.30USD-0.38%-0.02 today

MARKET CAP

1.1B

P/E (TTM)

FWD P/E

DAY RANGE

$5 – $5

52W RANGE

$3
$7

AI Summary

Stalk
StalkMedium

The stock remains in a secular uptrend as 50- and 200-day SMAs slope higher, but short-term price is choppy between EMAs with neutral momentum. Medium-term bias is bullish on support near the 50-day SMA around $5.50–$5.60, yet entries should be deferred until a pullback into that area and confirmed acceptance off moving-average support rather than chasing the current consolidation near $5.75.

  • Phase 3 molgramostim data from IMPALA-2 suggests FDA approval
  • $10.94 target price implies ~97% upside potential
  • Negative earnings yield and weak profitability factors raise survival doubts
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2020TREND
Sales, Adj.$257,000
YoY %
P / Sales265.4x
EV / Sales306.2x
Gross Profit, Adj.$257,000
YoY %
Margin %100.0%
EV / Gross Profit306.2x
EBITDA, Adj.$-49.0M
YoY %+5.4%
Margin %-19083.7%
EV / EBITDA-1.6x
EBIT$-49.3M
YoY %+37.6%
Margin %-19182.9%
EV / EBIT-1.6x
Net Income$-49.6M
YoY %+36.5%
Net Margin-19305.4%
EPS (GAAP)-$0.84
YoY %+56.9%